Annual Total Long Term Liabilities
$258.40 M
+$133.05 M+106.13%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual total long term liabilities is $258.40 million, with the most recent change of +$133.05 million (+106.13%) on December 31, 2023.
- During the last 3 years, AXSM annual total long term liabilities has risen by +$209.50 million (+428.40%).
- AXSM annual total long term liabilities is now at all-time high.
Performance
AXSM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$272.37 M
+$13.57 M+5.24%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly total long term liabilities is $272.37 million, with the most recent change of +$13.57 million (+5.24%) on September 30, 2024.
- Over the past year, AXSM quarterly long term liabilities has increased by +$13.97 million (+5.41%).
- AXSM quarterly long term liabilities is now at all-time high.
Performance
AXSM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AXSM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +106.1% | +5.4% |
| 3 y3 years | +428.4% | +453.9% |
| 5 y5 years | +7039.4% | +1325.4% |
AXSM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +426.4% | at high | +454.9% |
| 5 y | 5-year | at high | +1390.9% | at high | +1881.7% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Axsome Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $272.37 M(+5.2%) |
| Jun 2024 | - | $258.80 M(+0.5%) |
| Mar 2024 | - | $257.64 M(-0.3%) |
| Dec 2023 | $258.40 M(+106.1%) | $258.40 M(+19.3%) |
| Sep 2023 | - | $216.69 M(-0.5%) |
| Jun 2023 | - | $217.86 M(+23.3%) |
| Mar 2023 | - | $176.72 M(+41.0%) |
| Dec 2022 | $125.36 M(+155.4%) | $125.36 M(+3.3%) |
| Sep 2022 | - | $121.31 M(-1.2%) |
| Jun 2022 | - | $122.79 M(+149.0%) |
| Mar 2022 | - | $49.31 M(+0.5%) |
| Dec 2021 | $49.09 M(+0.4%) | $49.09 M(-0.2%) |
| Sep 2021 | - | $49.17 M(+0.4%) |
| Jun 2021 | - | $48.96 M(+0.1%) |
| Mar 2021 | - | $48.93 M(+0.0%) |
| Dec 2020 | $48.90 M(+182.1%) | $48.90 M(+1.8%) |
| Sep 2020 | - | $48.03 M(+249.4%) |
| Jun 2020 | - | $13.74 M(-11.6%) |
| Mar 2020 | - | $15.54 M(-10.3%) |
| Dec 2019 | $17.33 M | $17.33 M(-9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $19.11 M(+9.7%) |
| Jun 2019 | - | $17.42 M(-7.4%) |
| Mar 2019 | - | $18.82 M(+419.9%) |
| Dec 2018 | $3.62 M(-45.7%) | $3.62 M(-18.5%) |
| Sep 2018 | - | $4.44 M(-14.5%) |
| Jun 2018 | - | $5.19 M(-12.5%) |
| Mar 2018 | - | $5.93 M(-11.0%) |
| Dec 2017 | $6.66 M(-29.6%) | $6.66 M(-9.7%) |
| Sep 2017 | - | $7.38 M(-8.7%) |
| Jun 2017 | - | $8.08 M(-8.0%) |
| Mar 2017 | - | $8.78 M(-7.3%) |
| Dec 2016 | $9.47 M(>+9900.0%) | $9.47 M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $12.56 M(+150.3%) |
| Dec 2014 | $5.02 M(>+9900.0%) | $5.02 M |
| Dec 2013 | $0.00 | - |
FAQ
- What is Axsome Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics annual total long term liabilities year-on-year change?
- What is Axsome Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly long term liabilities year-on-year change?
What is Axsome Therapeutics annual total long term liabilities?
The current annual total long term liabilities of AXSM is $258.40 M
What is the all time high annual total long term liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total long term liabilities is $258.40 M
What is Axsome Therapeutics annual total long term liabilities year-on-year change?
Over the past year, AXSM annual total long term liabilities has changed by +$133.05 M (+106.13%)
What is Axsome Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AXSM is $272.37 M
What is the all time high quarterly long term liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total long term liabilities is $272.37 M
What is Axsome Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AXSM quarterly total long term liabilities has changed by +$13.97 M (+5.41%)